Description

7-[(2-Methylpropan-2-Yl)Oxycarbonyl]-6,8-Dihydro-5H-Imidazo[1,5-A]Pyrazine-1-Carboxylic Acid is a high-purity, advanced pharmaceutical intermediate featuring a complex imidazopyrazine heterocyclic core. This compound is of significant value for its role as a key building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring sophisticated molecular architectures. It is primarily sought after by research institutions and pharmaceutical manufacturers engaged in the development of new drugs, including potential candidates for oncology and central nervous system (CNS) disorders.

Application

• Pharmaceutical Intermediate: A critical precursor in the multi-step synthesis of complex drug molecules and investigational new drugs (INDs).
• Medicinal Chemistry Research: Serves as a versatile scaffold for structure-activity relationship (SAR) studies and library synthesis in drug discovery programs.
• API Development: Used in the process development and scale-up of new active pharmaceutical ingredients, especially those containing fused heterocyclic systems.
• Contract Research & Manufacturing (CRAM): Supplied to CROs and CDMOs supporting global pharmaceutical innovation pipelines.
• Chemical Biology Probes: Potential use in the development of specialized probes for studying biological pathways and target validation.

Basic Information

Product Name	7-[(2-Methylpropan-2-Yl)Oxycarbonyl]-6,8-Dihydro-5H-Imidazo[1,5-A]Pyrazine-1-Carboxylic Acid
CAS No.	1160248-16-7
Molecular Formula	C12H15N3O4
Molecular Weight	265.27 g/mol
Synonyms	1-[(tert-Butoxy)carbonyl]-6,8-dihydro-5H-imidazo[1,5-a]pyrazine-7-carboxylic acid; 7-(tert-Butoxycarbonyl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazine-1-carboxylic acid; 5H-Imidazo[1,5-a]pyrazine-1-carboxylic acid, 6,8-dihydro-7-[(2-methyl-1-oxopropoxy)carbonyl]-; Boc-Protected Imidazopyrazine Carboxylic Acid; tert-Butyl 1-carboxy-5,7-dihydroimidazo[1,5-a]pyrazine-6(8H)-carboxylate
EINECS	Contact for details

Quality Control

Our production of this advanced intermediate adheres to strict quality management systems, ensuring batch-to-batch consistency suitable for pharmaceutical R&D and scale-up. Quality is verified through comprehensive analytical techniques including HPLC, NMR, and mass spectrometry. A detailed Certificate of Analysis (COA) is provided with each batch, confirming identity, purity, and impurity profiles. We support compliance with relevant guidelines for pharmaceutical starting materials.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed after opening to minimize exposure to atmospheric moisture. For long-term storage, consider using desiccants.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC)	Conforms to reference standard
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.5%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.